Home > News > VivaGel™ receives fast track status from FDA
January 9th, 2006
VivaGel™ receives fast track status from FDA
Abstract:
Starpharma (ASX:SPL, USOTC:SPHRY) today announced that the US Food & Drug Administration (FDA) has granted Fast Track status to VivaGel™, an Investigational New Drug (IND) for the prevention of HIV.
Source:
biotech-intelligence.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||